Contemporary Lipid Management in Family Practice: Risk Stratification, Coronary Artery Calcium, and Shared Decision-Making for Statin Therapy Review Abstract Purpose: This paper examines current approaches to lipid management in family practice, focusing on risk stratification methods, the role of coronary artery calcium scoring, and implementation of
Tag: dyslipidemia
The Truth About Statin Intolerance Symptoms: Myth or Reality?
The Truth About Statin Intolerance Symptoms Myth or Reality Introduction Statin intolerance represents a major clinical challenge in lipid management and cardiovascular disease prevention. Reported symptoms range from muscle pain and weakness to fatigue and gastrointestinal disturbances, affecting between 5 and 30 percent of patients prescribed
Statin Therapy To Smash Cardiovascular Risk In Diabetic Patients
Statin Therapy To Smash Cardiovascular Risk In Diabetic Patients Overview The study aimed to assess the impact of statin therapy on preventing cardiovascular diseases (CVDs) in patients with type 2 diabetes mellitus (T2DM), considering their baseline low-density lipoprotein cholesterol (LDL-C) levels. Researchers analyzed data from electronic medical records in Hong Kong spanning
Drug Preferences Among Patients And Physicians For Diagnosed Dyslipidemia
Drug Preferences Among Patients And Physicians For Diagnosed Dyslipidemia Overview The study focused on evaluating patient and physician drug preferences regarding lipid-lowering drugs, particularly proprotein convertase subtilisin/kexin type 9 inhibitors, as an alternative to statins for dyslipidemia treatment. Employing an online discrete choice experiment (DCE), the research aimed to ascertain the relative
